Herbert Irving Comprehensive Cancer Center
Melissa Accordino, MD

Dr. Accordino graduated from The Pennsylvania State University with a bachelor of science in Pre-medicine with minors in Health Policy and Administration and Biology. She completed her medical degree at The Pennsylvania State University College of Medicine. While in medical school she was elected to Alpha Omega Alpha, the national medical honor society which recognizes high educational achievement. She completed her Internal Medicine residency at Weill Cornell Medical Center and her Medical Hematology/Oncology fellowship at Columbia University Medical Center, where she served as Chief Fellow. During that time, she was awarded a Conquer Cancer Foundation of the American Society of Clinical Oncology Young Investigator Award and Merit Award. She also served as a Postdoctoral Research Fellow in Cancer-Related Population Sciences supported by the National Cancer Institute for her work in quality improvement and health outcomes research.

Upon fellowship graduation she became an Assistant Professor of Medicine within the Division of Hematology/Oncology at Columbia University. Since her faculty appointment she has received grant funding from multiple agencies including: The American Society of Clinical Oncology, The HOPE Foundation, The Breast Cancer Research Foundation, The American Cancer Society, and the National Institutes of Health/National Cancer Institute. Dr. Accordino is currently involved in patient care, clinical research, education, and quality improvement.

Dr. Accordino’s research aims to improve the quality and delivery of cancer care, and cancer survivorship. Dr. Accordino participates in clinical trials at the local, national, and international level. She also has experience leading multicenter cancer trials through the SWOG Cooperative Group. The overall goal of her research is to improve quality and outcomes within oncology.

Clinical Studies Managed By This Investigator:
Condition Study Title
Breast Cancer [ CLOSED ] Study of efficacy of ribociclib plus fulvestrant in patients with metastatic breast cancer
Breast Cancer [ CLOSED ] The CONTRoL Trial: Cryotherapy vs. cOmpression Neuropathy TRiaL (in Breast Cancer Patients)
Breast Cancer Study Comparing Survival of Patients Monitored with Serum Tumor Marker Directed Disease Versus Usual Care in Metastatic Breast Cancer
Breast Cancer [ CLOSED ] ASPIRE: Study of Anastrozole, Palbociclib, Trastuzumab and Pertuzumab Metastatic Breast Cancer
Breast Cancer [ CLOSED ] Study of HER2 Negative, Locally Recurrent or Metastatic Breast Cancer (FORTRESS)
Breast Cancer [ CLOSED ] Study for Patients With PIK3CA-Mutant, Hormone Receptor-Positive, Her2-Negative, Locally Advanced or Metastatic Breast Cancer
Cancer [ CLOSED ] Smartphone App for Cancer Medication Adherence
Breast Cancer [ CLOSED ] Glucose Monitoring to Determine Rates of Hyperglycemia During Chemotherapy for Early Stage Breast Cancer
Cancer Cooling and Compression to Prevent Nerve Damage During Chemotherapy